Your browser doesn't support javascript.
loading
Targeting of Aberrant αvß6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells.
Whilding, Lynsey M; Parente-Pereira, Ana C; Zabinski, Tomasz; Davies, David M; Petrovic, Roseanna M G; Kao, Y Vincent; Saxena, Shobhit A; Romain, Alex; Costa-Guerra, Jose A; Violette, Shelia; Itamochi, Hiroaki; Ghaem-Maghami, Sadaf; Vallath, Sabari; Marshall, John F; Maher, John.
Afiliação
  • Whilding LM; King's College London, King's Health Partners Integrated Cancer Centre and Division of Cancer Studies, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
  • Parente-Pereira AC; King's College London, King's Health Partners Integrated Cancer Centre and Division of Cancer Studies, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
  • Zabinski T; King's College London, King's Health Partners Integrated Cancer Centre and Division of Cancer Studies, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
  • Davies DM; King's College London, King's Health Partners Integrated Cancer Centre and Division of Cancer Studies, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
  • Petrovic RMG; King's College London, King's Health Partners Integrated Cancer Centre and Division of Cancer Studies, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
  • Kao YV; King's College London, King's Health Partners Integrated Cancer Centre and Division of Cancer Studies, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
  • Saxena SA; King's College London, King's Health Partners Integrated Cancer Centre and Division of Cancer Studies, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
  • Romain A; King's College London, King's Health Partners Integrated Cancer Centre and Division of Cancer Studies, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
  • Costa-Guerra JA; King's College London, King's Health Partners Integrated Cancer Centre and Division of Cancer Studies, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
  • Violette S; Biogen Idec, Cambridge, MA 02142, USA.
  • Itamochi H; Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Iwate 020-8505, Japan.
  • Ghaem-Maghami S; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK.
  • Vallath S; Centre for Tumour Biology, John Vane Science Centre, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
  • Marshall JF; Centre for Tumour Biology, John Vane Science Centre, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
  • Maher J; King's College London, King's Health Partners Integrated Cancer Centre and Division of Cancer Studies, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK; Department of Clinical Immunology and Allergy, King's College Hospital NHS Foundation Trust, Denmark Hill, London SE5 9RS, UK; Department of Imm
Mol Ther ; 25(1): 259-273, 2017 01 04.
Article em En | MEDLINE | ID: mdl-28129120
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Receptores de Antígenos de Linfócitos T / Integrinas / Subpopulações de Linfócitos / Engenharia Celular / Antígenos de Neoplasias / Neoplasias Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Receptores de Antígenos de Linfócitos T / Integrinas / Subpopulações de Linfócitos / Engenharia Celular / Antígenos de Neoplasias / Neoplasias Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article